GreenLight Biosciences Stock (NASDAQ:GRNA)
Previous Close
$0.30
52W Range
$0.18 - $5.90
50D Avg
$0.27
200D Avg
$0.85
Market Cap
$45.43M
Avg Vol (3M)
$684.80K
Beta
1.44
Div Yield
-
GRNA Company Profile
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
GRNA Performance
Peer Comparison
| Ticker | Company |
|---|---|
| SNTI | Senti Biosciences, Inc. |
| ZVSA | ZyVersa Therapeutics, Inc. |
| BDRX | Biodexa Pharmaceuticals Plc |
| NTRB | Nutriband Inc. |
| ONCR | Oncorus, Inc. |
| LEXX | Lexaria Bioscience Corp. |
| BWV | Onconetix, Inc. |
| FHTX | Foghorn Therapeutics Inc. |
| CVKD | Cadrenal Therapeutics, Inc. Common Stock |
| PXMD | PaxMedica, Inc. Common Stock |
| LGVN | Longeveron Inc. |
| REVB | Revelation Biosciences, Inc. |
| QNRX | Quoin Pharmaceuticals, Ltd. |
| HILS | Tharimmune, Inc. |
| VRAX | Virax Biolabs Group Limited |
| RNXT | RenovoRx, Inc. |